Back to search

Article

Characterizing the Biopotency of Truncated Transgene Variants in rAAV8 viral vectors: Essential Considerations for Gene Therapy Applications

2024-04-04

Abstract excerpt

<title>Abstract</title> <p>Background The production of recombinant Adeno-Associated Virus (rAAV) vectors for gene therapy applications is a critical process, especially when dealing with large transgenes that challenge the 4.7kb capacity limit of rAAV. We aimed to investigate the variances in recombinant rAAV samples post-ultracentrifugation produced in HEK293, focusing on those rAAV8s with either single-strand...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b3057c8-b8af-5b21-946a-1f01721d581e
DOI
10.21203/rs.3.rs-4043201/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Characterizing the Biopotency of Truncated Transgene Variants in rAAV8 viral vectors: Essential Considerations for Gene Therapy ApplicationsDOI 10.21203/rs.3.rs-4043201/v1
Select a neighboring publication to make it the new centre.